Eurofins Scientific

Top-line growth improves in Q3

08/11/19 -"Eurofins reported reassuring top-line growth in Q3 FY19 – the performance was spread across all geographies except for the UK. The growth is likely to be sustained in Q4 FY19, in our opinion. ..."

PDF page sample
Pages
55
Language
English
Published on
08/11/19
Download
You may also be interested by these reports :
10/07/25
Leap 28 II
30/06/25
DKSH (ADD; Switzerland) is an attractive market expansion services (‘MES’) provider with leading positions in largely-fragmented target markets, ...
22/05/25
The 2024 EPS included a €139m fair value adjustment and impairment related to loans and financial commitments towards CareerBuilder and Monster, ...
15/05/25
Experian reported FY24/25 results in line with expectations, with 7% organic revenue growth and 11% EBIT growth. North America led, offsetting weaker ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO